Cargando…
Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design
Herein we present, an exhaustive docking analysis considering the case of autotaxin (ATX). HA155, a small molecule inhibitor of ATX, is co-crystallized. In order to further extract conclusions on the nature of the bond formed between the ligands and the amino acid residues of the active site, densit...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273881/ https://www.ncbi.nlm.nih.gov/pubmed/27617984 http://dx.doi.org/10.3390/molecules21091185 |
_version_ | 1783377489821696000 |
---|---|
author | Katsamakas, Sotirios Papadopoulos, Anastasios G. Hadjipavlou-Litina, Dimitra |
author_facet | Katsamakas, Sotirios Papadopoulos, Anastasios G. Hadjipavlou-Litina, Dimitra |
author_sort | Katsamakas, Sotirios |
collection | PubMed |
description | Herein we present, an exhaustive docking analysis considering the case of autotaxin (ATX). HA155, a small molecule inhibitor of ATX, is co-crystallized. In order to further extract conclusions on the nature of the bond formed between the ligands and the amino acid residues of the active site, density functional theory (DFT) calculations were undertaken. However, docking does not provide reproducible results when screening boronic acid derivatives and their binding orientations to protein drug targets. Based on natural bond orbital (NBO) calculations, the formed bond between Ser/Thr residues is characterized more accurately as a polar covalent bond instead of a simple nonpolar covalent one. The presented results are acceptable and could be used in screening as an active negative filter for boron compounds. The hydroxyl groups of amino acids are bonded with the inhibitor’s boron atom, converting its hybridization to sp(3). |
format | Online Article Text |
id | pubmed-6273881 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62738812018-12-28 Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design Katsamakas, Sotirios Papadopoulos, Anastasios G. Hadjipavlou-Litina, Dimitra Molecules Article Herein we present, an exhaustive docking analysis considering the case of autotaxin (ATX). HA155, a small molecule inhibitor of ATX, is co-crystallized. In order to further extract conclusions on the nature of the bond formed between the ligands and the amino acid residues of the active site, density functional theory (DFT) calculations were undertaken. However, docking does not provide reproducible results when screening boronic acid derivatives and their binding orientations to protein drug targets. Based on natural bond orbital (NBO) calculations, the formed bond between Ser/Thr residues is characterized more accurately as a polar covalent bond instead of a simple nonpolar covalent one. The presented results are acceptable and could be used in screening as an active negative filter for boron compounds. The hydroxyl groups of amino acids are bonded with the inhibitor’s boron atom, converting its hybridization to sp(3). MDPI 2016-09-07 /pmc/articles/PMC6273881/ /pubmed/27617984 http://dx.doi.org/10.3390/molecules21091185 Text en © 2016 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Katsamakas, Sotirios Papadopoulos, Anastasios G. Hadjipavlou-Litina, Dimitra Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design |
title | Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design |
title_full | Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design |
title_fullStr | Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design |
title_full_unstemmed | Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design |
title_short | Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design |
title_sort | boronic acid group: a cumbersome false negative case in the process of drug design |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273881/ https://www.ncbi.nlm.nih.gov/pubmed/27617984 http://dx.doi.org/10.3390/molecules21091185 |
work_keys_str_mv | AT katsamakassotirios boronicacidgroupacumbersomefalsenegativecaseintheprocessofdrugdesign AT papadopoulosanastasiosg boronicacidgroupacumbersomefalsenegativecaseintheprocessofdrugdesign AT hadjipavloulitinadimitra boronicacidgroupacumbersomefalsenegativecaseintheprocessofdrugdesign |